Related Articles
FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma
Genetic alterations in epidermal growth factor receptor‑tyrosine kinase inhibitor‑naïve non‑small cell lung carcinoma
Prognostic significance of ABCB1 in stage I lung adenocarcinoma
Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status
Cetuximab promotes anticancer drug toxicity in rhabdomyosarcomas with EGFR amplification in vitro